The distribution of electrophoretic variants in 8 red cell enzyme systems, representing 10 independent gene loci, has been examined in a large series of Marathi and Gujarati blood samples from Bombay. In the acid phosphatase system no PHsc genes were detected in Marathis and the frequency of PHsc in Gujaratis was only 0.004. The PHsB frequencies were 0.72 and 0.71 respectively. For 6-phosphogluconate dehydrogenase the PGDA frequencies were 0.97 and 0.98: a single case of the ‘Richmond’ variant was found in Gujaratis. The AK2 gene in the adenylate kinase system has a relatively high frequency, as in other Indian populations: the respective frequencies were 0.09 and 0.11. No variants were found at the PGM2 locus in the phosphoglucomutase system. For the PGMX locus PGM]1 frequencies were 0.65 and 0.69 for Marathis and Gujaratis. A single PGM 6–1 individual was found in the Marathis and a PGM 3–1 individual in the Gujaratis. No electrophoretic variant was found for the peptidase A, malate dehydrogenase or ‘oxidase’ systems. A single Pep B 2–1 person was found among the Marathis in the peptidase B system. Fourteen cases of the ‘Calcutta-1’ variant were found among 1,005 persons tested for lactate dehydrogenase. The LDH ‘Cal-1’ gene frequency was 0.0089 for Marathis and 0.005 for Gujaratis. The ‘Cal-1’ variant is widespread in India and has the highest world frequency for any LDH variant.

Keywords:
Red cell enzyme group systems, Indian population study
This content is only available via PDF.
© 1970 S. Karger AG, Basel
1970
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.